Aparna Pharmaceuticals - About the company
Aparna Pharmaceuticals is a seed company based in Hyderabad (India), founded in 2008 by Rakesh Reddy. It operates as a CDMO focused on manufacturing API intermediates. Aparna Pharmaceuticals has raised $674K in funding from Care Ind Chem and Loven Labs, with a current valuation of ₹*****. The company has 145 active competitors, including 9 funded and 14 that have exited. Its top competitors include companies like Blue Jet Healthcare, Viyash and Vivimed Labs.
Company Details
- Website
- aparnapharma.com
- Phone Number
- +91 **********
- Registered Address
- 802, Astral Heights, Road No.1 Banjara Hills, Hyderabad, Hyderabad, Telangana, India, 500034
Key Metrics
Legal entities associated with Aparna Pharmaceuticals
Aparna Pharmaceuticals is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
APARNA ORGANICS LIMITED CIN: U24232TG2008PLC058745 , India, Amalgamated | Apr 21, 2008 | $6.25M (As on Mar 31, 2023) | 328 (As on Mar 31, 2024) | |
APARNA PHARMACEUTICALS PRIVATE LIMITED CIN: U24304TG2020PTC143375 , India, Active | Sep 01, 2020 | $23.6M (As on Mar 31, 2025) | 289 (As on May 31, 2025) |
Sign up to download Aparna Pharmaceuticals' company profile
Aparna Pharmaceuticals's funding and investors
Aparna Pharmaceuticals has raised a total funding of $674K over 2 rounds. Its first funding round was on Oct 12, 2016. Its latest funding round was a Seed round on Mar 11, 2017 for $*****. 1 investor participated in its latest round. Aparna Pharmaceuticals has 4 institutional investors and 34 angel investors.
Here is the list of recent funding rounds of Aparna Pharmaceuticals:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 11, 2017 | 2945033 | Seed | 3971145 | 5407590 | 8122391 | 6145870 |
Oct 12, 2016 | 1931695 | Seed | 9600075 | 6323354 | 1286927 |
Access funding benchmarks and valuations. Sign up today!View details of Aparna Pharmaceuticals's funding rounds and investors
Aparna Pharmaceuticals' founders and board of directors
Founder? Claim ProfileThe founders of Aparna Pharmaceuticals is Rakesh Reddy.
Here are the details of Aparna Pharmaceuticals' key team members:
- Rakesh Reddy: Founder & Director of Aparna Pharmaceuticals. They are also an angel investor in 1 startup.
View details of Aparna Pharmaceuticals's Founder profiles and Board Members
Aparna Pharmaceuticals' employee count trend
Aparna Pharmaceuticals has 46 employees as of Mar 26. Here is Aparna Pharmaceuticals's employee count trend over the years:
Uncover Aparna Pharmaceuticals' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Aparna Pharmaceuticals's Competitors and alternates
Top competitors of Aparna Pharmaceuticals include Blue Jet Healthcare, Viyash and Vivimed Labs. Here is the list of Top 10 competitors of Aparna Pharmaceuticals, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Blue Jet Healthcare 1969, Mumbai (India), Public | CDMO focused on manufacturing, supplier, and development of intermediates & APIs | - | - | 57/100 |
2nd | CDMO focused on manufacturing of APIs & intermediates | $120M | 57/100 | ||
3rd | Vivimed Labs 1988, Hyderabad (India), Public | Manufacturer of APIs, formulations and specialty chemicals | - | 53/100 | |
4th | Custom based manufacturer of actives, crop protection, advanced intermediates, and specialty chemicals | $30.2M | 46/100 | ||
5th | Ami organics 2007, Surat (India), Public | Pharmaceutical company manufacturing active pharmaceutical ingredient (API) intermediates | - | 43/100 | |
6th |  Veranova 2022, Wayne (United States), Acquired | CDMO focused on manufacturing of APIs and intermideates | - | - | 42/100 |
7th | Lofty Laboratories 2005, India, Unfunded | CDMO focused on manufacturing pharmaceutical intermediates | - | - | 41/100 |
8th |  Valence Labs 2021, Rajpura (India), Unfunded | Manufacturer of pharmaceutical API for forefront of chemical innovation | - | - | 41/100 |
9th |  Sionc Pharmaceuticals 2010, Visakhapatnam (India), Unfunded | CDMO focused on manufacturing of complex and niche active pharmaceutical ingredients | - | - | 39/100 |
10th |  Kalintis Healthcare 2014, Vadodara (India), Unfunded | CDMO focused on manufacturing of API & intermediates | - | - | 39/100 |
13th | Aparna Pharmaceuticals 2008, Hyderabad (India), Seed | CDMO focused on manufacturing API intermediates | $674K | 32/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Aparna Pharmaceuticals's competitors? Click here to see the top ones
Aparna Pharmaceuticals's Investments and acquisitions
Aparna Pharmaceuticals has made no investments or acquisitions yet.
News related to Aparna Pharmaceuticals
•
•
Aparna Pharma receives USFDA clearance for manufacturing unit in Andhra PradeshBioSpectrum India•Feb 12, 2024•Aparna Pharmaceuticals
•
USFDA pulls up Lantech Pharma for manufacturing violations at Andhra plantBusiness Standard•Aug 29, 2019•Aparna Pharmaceuticals, Lantech Pharmaceuticals
•
FDA cites solvent recovery firm as a player in the valsartan messFiercepharma•Aug 15, 2019•Aparna Pharmaceuticals
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Aparna Pharmaceuticals
Explore our recently published companies
- Bio Growth Lab Services - Chennai based, 2022 founded, Unfunded company
- DB Plumbing Heating - Nutley based, 2020 founded, Unfunded company
- GRT - Shanghai based, 2010 founded, Funding Raised company
